To obtain further mechanistic insights, we compared the gene expression profiles of tumors from 104 CRC patients (GSE21510) 30 with higher dysadherin expression (dysadherinhigh) versus lower dysadherin expression (dysadherinlow). This evidence concerns the gene FXYD5 and colorectal carcinoma.